Scientists at the Pasteur Institute in France say they have developed artificial lymphoid organ-chips that recreate much of the human immune system’s response to booster vaccines. The technology, ...

Pulmonary MALT lymphoma is a rare and typically slow-growing cancer that affects B cells in the mucous lining of your lungs. It may not cause symptoms and has higher survival rates than other types of ...

Individuals who are immunocompromised are considered at higher risk for severe or longer disease with COVID-19. Understanding the systemic immune response is vital for research efforts to reduce its ...

Lymphoid-derived conventional dendritic cells (L-cDCs) may play a unique function associated with immune suppression and allergy induction, as reported by researchers from Japan. Long thought to arise ...

Background: Pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma is a rare, indolent subtype of non-Hodgkin lymphoma with distinct radiological and pathological characteristics. Clinically, ...

In a recent study published in Immunology, researchers investigated populations of regulatory T cells (Treg), a type of white blood cell, in various tissues. Study: The tissue-resident regulatory T ...

Researchers at Heinrich Heine University Düsseldorf (HHU) and University Hospital Düsseldorf (UKD) have succeeded in mapping the organisation of immune cells in human lymph nodes for the first time.

Lymph nodes are key control centers in the immune system and play an important role in defending the body against infections ...

A new study maps the organisation of immune and stromal cells in lymph nodes and shows how loss of this organisation affects ...

What Is Marginal Zone Lymphoma? Marginal zone lymphoma (MZL) isn’t one disease, but a group of rare, slow-growing blood cancers. They’re known as non-Hodgkin lymphomas because they start in your ...